DC Funds’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $642K | Hold |
589,102
| – | – | 29.83% | 2 |
|
|
2025
Q1 | $573K | Hold |
589,102
| – | – | 27.71% | 3 |
|
|
2024
Q4 | $872K | Hold |
589,102
| – | – | 24.47% | 2 |
|
|
2024
Q3 | $1.25M | Hold |
589,102
| – | – | 24.25% | 2 |
|
|
2024
Q2 | $1.44M | Hold |
589,102
| – | – | 23.87% | 2 |
|
|
2024
Q1 | $3.82M | Hold |
589,102
| – | – | 36.89% | 2 |
|
|
2023
Q4 | $2.27M | Hold |
589,102
| – | – | 27.34% | 3 |
|
|
2023
Q3 | $1.26M | Hold |
589,102
| – | – | 25.95% | 3 |
|
|
2023
Q2 | $1.8M | Hold |
589,102
| – | – | 38.27% | 1 |
|
|
2023
Q1 | $1.53M | Hold |
589,102
| – | – | 35.68% | 1 |
|
|
2022
Q4 | $1.21M | Hold |
589,102
| – | – | 32.7% | 2 |
|
|
2022
Q3 | $2.66M | Hold |
589,102
| – | – | 40.05% | 1 |
|
|
2022
Q2 | $2.41M | Hold |
589,102
| – | – | 33.24% | 2 |
|
|
2022
Q1 | $2.59M | Buy |
589,102
+8,200
| +1% | +$36.1K | 33.68% | 2 |
|
|
2021
Q4 | $6.92M | Sell |
580,902
-8,200
| -1% | -$97.7K | 40.97% | 2 |
|
|
2021
Q3 | $10.1M | Hold |
589,102
| – | – | 39.69% | 1 |
|
|
2021
Q2 | $10.3M | Buy |
+589,102
| New | +$10.3M | 48.81% | 2 |
|